1. Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity. (16th January 2015) Authors: Singh, Shiv K; Chen, Nai‐Ming; Hessmann, Elisabeth; Siveke, Jens; Lahmann, Marlen; Singh, Garima; Voelker, Nadine; Vogt, Sophia; Esposito, Irene; Schmidt, Ansgar; Brendel, Cornelia; Stiewe, Thorsten; Gaedcke, Jochen; Mernberger, Marco; Crawford, Howard C; Bamlet, William R; Zhang, Jin‐San; Li, Xi... Journal: EMBO journal Issue: Volume 34:Number 4(2015) Page Start: 517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early detection and imaging strategies to reveal and target developing pancreatic cancer. Issue 2 (1st February 2020) Authors: Crawford, Howard C; Wallace, Michael B.; Storz, Peter Journal: Expert review of anticancer therapy Issue: Volume 20:Issue 2(2020) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy. Issue 9 (25th June 2014) Authors: Takeuchi, Kenneth K; Crawford, Howard C Journal: Gut Issue: Volume 63:Issue 9(2014) Page Start: 1379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗